SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD)

European Neuropsychopharmacology

Volumn 15, Issue 5, 2005, Pages 521-524

  Pogarell, Oliver ^a   Poepperl, Gabriele ^a   Mulert, Christoph ^a   Hamann, Christine ^a   Sadowsky, Nikolai ^a   Riedel, Michael ^a   Moeller, Hans Juergen ^a   Hegerl, Ulrich ^a   Tatsch, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

CIT; Obsessive compulsive disorder; Serotonin and dopamine transporters; Serotonin reuptake inhibitor; Single photon emission computed tomography

Indexed keywords

2 BETA CARBOMETHOXY 3 BETA (4 IODOPHENYL)TROPANE; CITALOPRAM; DOPAMINE TRANSPORTER; IODINE 123; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOAVAILABILITY; CASE REPORT; CLINICAL TRIAL; DOPAMINERGIC ACTIVITY; DRUG MECHANISM; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN; CITALOPRAM; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 24044456947     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.01.003     Document Type: Article

References (23)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Press Washington, DC
2. H.G. Baumgarten, and Z. Grozdanovic Role of serotonin in obsessive-compulsive disorder Br. J. Psychiatry 137 Suppl. 35 1998 13 20
3. H.T. Benamer, W.H. Oertel, J. Patterson, D.M. Hadley, O. Pogarell, H. Hoffken, A. Gerstner, and D.G. Grosset Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations Mov. Disord. 18 2003 977 984
4. T. Brücke, J. Kornhuber, P. Angelberger, S. Asenbaum, H. Frassine, and I. Podreka SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain J. Neural Transm., Gen. Sect. 94 1993 137 146
5. P.E. Gerber, and L.D. Lynd Selective serotonin-reuptake inhibitor-induced movement disorders Ann. Pharmacother. 32 1998 692 698
6. J. Hyttel Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) Int. Clin. Psychopharmacol. 9 S1 1994 19 26
7. J. Ichikawa, and H.Y. Meltzer Effect of antidepressants on striatal and accumbens extracellular dopamine levels Eur. J. Pharmacol. 281 1995 255 261
8. A. Kugaya, N.M. Seneca, P.J. Snyder, S.A. Williams, R.T. Malison, R.M. Baldwin, J.P. Seibyl, and R.B. Innis Changes in human in vivo serotonin and dopamine transporter availability during chronic antidepressant administration Neuropsychopharmacology 28 2003 413 420
9. M. Laruelle, R.M. Baldwin, R.T. Malison, Y. Zea-Ponce, S.S. Zoghbi, M.S. al-Tikriti, E.H. Sybirska, R.C. Zimmermann, G. Wisniewski, J.L. Neumeyer, R.A. Milius, S. Wang, E.O. Smith, R.H. Roth, D.S. Charney, P.B. Hoffer, and R.B. Innis SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates Synapse 13 1993 295 309
10. M. Laruelle, E. Wallace, J.P. Seibyl, R.M. Baldwin, Y. Zea-Ponce, S.S. Zoghbi, J.L. Neumeyer, D.S. Charney, P.B. Hoffer, and R.B. Innis Graphical, kinetic, and equilibrium analyses of in vivo [123I]beta-CIT binding to dopamine transporters in healthy human subjects J. Cereb. Blood Flow Metab. 14 1994 982 994
11. R.T. Malison, L.H. Price, R. Berman, C.H. van Dyck, G.H. Pelton, L. Carpenter, G. Sanacora, M.J. Owens, C.B. Nemeroff, N. Rajeevan, R.M. Baldwin, J.P. Seibyl, R.B. Innis, and D.S. Charney Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography Biol. Psychiatry 44 1998 1090 1098
12. H. Moukhles, O. Bosler, J.P. Bolam, A. Vallee, D. Umbriaco, M. Geffard, and G. Doucet Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra Neuroscience 76 1997 1159 1171
13. L.H. Parsons, and J.B. Justice Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis Brain Res. 606 1993 195 199
14. W. Pirker, S. Asenbaum, S. Kasper, H. Walter, P. Angelberger, G. Koch, A. Pozzera, L. Deecke, I. Podreka, and T. Brücke Beta-CIT SPECT demonstrates blockade of 5 HT-uptake sites by citalopram in the human brain in vivo J. Neural Transm., Gen. Sect. 100 1995 247 256
15. W. Pirker, S. Asenbaum, M. Hauk, S. Kandlhofer, J. Tauscher, M. Willeit, A. Neumeister, N. Praschak-Rieder, P. Angelberger, and T. Brücke Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging J. Nucl. Med. 41 2000 36 44
16. O. Pogarell, C. Hamann, G. Pöpperl, G. Juckel, M. Choukèr, M. Zaudig, M. Riedel, H.J. Möller, U. Hegerl, and K. Tatsch Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder Biol. Psychiatry 54 2003 1406 1413
17. S. Saxena, A.L. Brody, M.L. Ho, S. Alborzian, K.M. Maidment, N. Zohrabi, M.K. Ho, S.C. Huang, H.M. Wu, and L.R. Baxter Jr. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression Arch. Gen. Psychiatry 59 2002 250 261
18. A. Schatzberg New indications for antidepressants J. Clin. Psychiatry 61 S11 2000 9 17
19. P. Schloss, and D.C. Williams The serotonin transporter: a primary target for antidepressant drugs J. Psychopharmacol. 12 1998 115 121
20. J. Schwarz, R. Linke, M. Kerner, P.D. Mozley, C. Trenkwalder, T. Gasser, and K. Tatsch Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis Arch. Neurol. 57 2000 205 208
21. T.D. Smith, R. Kuczenski, K. George-Friedman, J.D. Malley, and S.L. Foote In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration Synapse 38 2000 460 470
22. J.K. Staley, M. Basile, D.D. Flynn, and D.C. Mash Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization J. Neurochem. 62 1994 549 556
23. J. Tauscher, W. Pirker, M. de Zwaan, S. Asenbaum, T. Brucke, and S. Kasper In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment Eur. Neuropsychopharmacol. 9 1999 177 179